Allium compounds, dipropyl and dimethyl thiosulfinates as antiproliferative and differentiating agents of human acute myeloid leukemia cell lines

Biologics: Targets and Therapy

Volumn 2, Issue 4, 2008, Pages 885-895

  Merhi, Faten ^a   Auger, Jacques ^b   Rendu, Francine ^a   Bauvois, Brigitte ^a  

^a SORBONNE UNIVERSITÉ   (France)

^b UNIVERSITÉ DE TOURS   (France)

Author keywords

Acute myeloid leukemia; Differentiation; Matrix metalloproteinase 9; Proliferation; Thiosulfinate

Indexed keywords

EID: 79959454849     PISSN: 11775475     EISSN: 11775491     Source Type: Journal    
DOI: None     Document Type: Article

References (69)

1. Ackermann RT, Mulrow CD, Ramirez G, et al. 2001. Garlic shows promise for improving some cardiovascular risk factors. Arch Intern Med, 161:813-24.
2. Adachi S, Leoni LM, Carson DA, et al. 2004. Apoptosis induced by molecular targeting therapy in hematological malignancies. Acta Haematol, 111:107-23.
3. Amagase H. 2006. Clarifying the real bioactive constituents of garlic. J Nutr, 136:716S-25S.
4. Arnault I, Christides JP, Mandon N, et al. 2003. High-performance ion-pair chromatography method for simultaneous analysis of alliin, deoxyalliin, allicin and dipeptide precursors in garlic products using multiple mass spectrometry and UV detection. J Chromatogr A, 991:69-75.
5. Auger J, Lalau-Keraly F, Belinsky C. 1990. Thiosulfinates in vapor phase are stable and they can persist in the environment of allium. Chemosphr, 21:837-43.
6. Badol P, David-Dufilho M, Auger J, et al. 2007. Thiosulfinates modulate platelet activation by reaction with surface free sulfhydryls and internal thiol-containing proteins. Platelets, 18:481-90.
7. Barber N, Belov L, Christopherson RI. 2008. All-trans retinoic acid induces different immunophenotypic changes on human HL60 and NB4 myeloid leukaemias. Leuk Res, 32:315-22.
8. Baumgartner B, Weber M, Quirling M, et al. 2002. Increased IkappaB kinase activity is associated with activated NF-kappaB in acute myeloid blasts. Leukemia, 16:2062-71.
9. Bauvois B, Dumont J, Mathiot C, et al. 2002. Production of matrix metalloproteinase-9 in early stage B-CLL: suppression by interferons. Leukemia, 16:791-8.
10. Bergh G, Ehinger M, Olsson I, et al. 1999. Involvement of the retinoblastoma protein in monocytic and neutrophilic lineage commitment of human bone marrow progenitor cells. Blood, 94:1971-8.
11. Borek C. 2006. Garlic reduces dementia and heart-disease risk. J Nutr, 136:810S-2S.
12. Braun T, Carvalho G, Fabre C, et al. 2006. Targeting NF-kappaB in hematologic malignancies. Cell Death Differ, 13:748-58.
13. Cilloni D, Martinelli G, Messa F, et al. 2007. Nuclear factor kB as a target for new drug development in myeloid malignancies. Haematologica, 92:1224-9.
14. Collins SJ. 1987. The HL-60 promyelocytic leukemia cell line: proliferation, differentiation, and cellular oncogene expression. Blood, 70:1233-44.
15. De Benedetti F, Falk LA, Ellingsworth LR, et al. 1990. Synergy between transforming growth factor-beta and tumor necrosis factor-alpha in the induction of monocytic differentiation of human leukemic cell lines. Blood, 75:626-32.
16. Deryugina EI, Quigley JP. 2006. Matrix metalloproteinases and tumor metastasis. Cancer Metastasis Rev, 25:9-34.
17. Drexler HG, Matsuo Y. 1999. Guidelines for the characterization and publication of human malignant hematopoietic cell lines. Leukemia, 13:835-42.
18. Drexler HG, Quentmeier H, MacLeod RA. 2004. Malignant hematopoietic cell lines: in vitro models for the study of MLL gene alterations. Leukemia, 18:227-32.
19. Ferrara FF, Fazi F, Bianchini A, et al. 2001. Histone deacetylase-targeted treatment restores retinoic acid signaling and differentiation in acute myeloid leukemia. Cancer Res, 61:2-7.
20. Fiedler W, Graeven U, Ergun S, et al. 1997. Vascular endothelial growth factor, a possible paracrine growth factor in human acute myeloid leukemia. Blood, 89:1870-5.
21. Herman-Antosiewicz A, Singh SV. 2004. Signal transduction pathways leading to cell cycle arrest and apoptosis induction in cancer cells by Allium vegetable-derived organosulfur compounds: a review. Mutat Res, 555:121-31.
22. Hodge G, Davis S, Rice M, et al. 2008. Garlic compounds selectively kill childhood pre-B acute lymphoblastic leukemia cells in vitro without reducing T-cell function: Potential therapeutic use in the treatment of ALL. Biologics Targets and Therapy, 1:143-9.
23. Hosono T, Fukao T, Ogihara J, et al. 2005. Diallyl trisulfide suppresses the proliferation and induces apoptosis of human colon cancer cells through oxidative modification of beta-tubulin. J Biol Chem, 280:41487-93.
24. Ippoushi K, Itou H, Azuma K, et al. 2002. Effect of naturally occurring organosulfur compounds on nitric oxide production in lipopolysaccharide-activated macrophages. Life Sci, 71:411-19.
25. Jurcic JG, Soignet SL, Maslak AP. 2007. Diagnosis and treatment of acute promyelocytic leukemia. Curr Oncol Rep, 9:337-44.
26. Kamijo R, Takeda K, Nagumo M, et al. 1990. Effects of combinations of transforming growth factor-beta 1 and tumor necrosis factor on induction of differentiation of human myelogenous leukemic cell lines. J Immunol, 144:1311-16.
27. Keiss HP, Dirsch VM, Hartung T, et al. 2003. Garlic (Allium sativum L.) modulates cytokine expression in lipopolysaccharide-activated human blood thereby inhibiting NF-kappaB activity. J Nutr, 133:2171-5.
28. Khanna-Gupta A, Kolibaba K, Zibello TA, et al. 1994. NB4 cells show bilineage potential and an aberrant pattern of neutrophil secondary granule protein gene expression. Blood, 84:294-302.
29. Khanum F, Anilakumar KR, Viswanathan KR. 2004. Anticarcinogenic properties of garlic: a review. Crit Rev Food Sci Nutr, 44:479-88.
30. Kim YR, Abraham NG, Lutton JD. 1991. Mechanisms of differentiation of U937 leukemic cells induced by GM-CSF and 1,25(OH)2 vitamin D3. Leuk Res, 15:409-18.
31. King ME, Rowe JM. 2007. Recent developments in acute myelogenous leukemia therapy. Oncologist, 12(Suppl 2):14-21.
32. Kini AR, Peterson LA, Tallman MS, et al. 2001. Angiogenesis in acute promyelocytic leukemia: induction by vascular endothelial growth factor and inhibition by all-trans retinoic acid. Blood, 97:3919-24.
33. Klein G, Vellenga E, Fraaije MW, et al. 2004. The possible role of matrix metalloproteinase (MMP)-2 and MMP-9 in cancer, eg, acute leukemia. Crit Rev Oncol Hematol, 50:87-100.
34. Kwon KB, Yoo SJ, Ryu DG, et al. 2002. Induction of apoptosis by diallyl disulfide through activation of caspase-3 in human leukemia HL-60 cells. Biochem Pharmacol, 63:41-7.
35. Lanotte M, Martin-Thouvenin V, Najman S, et al. 1991. NB4, a maturation inducible cell line with t(15; 17) marker isolated from a human acute promyelocytic leukemia (M3). Blood, 77:1080-6.
36. Lanzotti V. 2006. The analysis of onion and garlic. J Chromatogr A, 1112:3-22.
37. Le Bon AM, Siess MH. 2000. Organosulfur compounds from Allium and the chemoprevention of cancer. Drug Metabol Drug Interact, 17:51-79.
38. Leone G, Sica S, Voso MT, et al. 2006. Treatment of acute leukaemias with monoclonal antibodies: current status and future prospects. Cardiovasc Hematol Agents Med Chem, 4:33-52.
39. Longo V, Vacca A, Ribatti D. 2007. Imaging and angiogenesis in hematological malignancies. Leukemia, 21:1605.
40. Lu R, Pitha PM. 2001. Monocyte differentiation to macrophage requires interferon regulatory factor 7. J Biol Chem, 276:45491-6.
41. Manzella L, Conte E, Cocchiaro G, et al. 1999. Role of interferon regulatory factor 1 in monocyte/macrophage differentiation. Eur J Immunol, 29:3009-16.
42. Martin SJ, Reutelingsperger CP, McGahon AJ, et al. 1995. Early redistribution of plasma membrane phosphatidylserine is a general feature of apoptosis regardless of the initiating stimulus: inhibition by overexpression of Bcl-2 and Abl. J Exp Med, 182:1545-56.
43. Mason KD, Juneja SK, Szer J. 2006. The immunophenotype of acute myeloid leukemia: is there a relationship with prognosis? Blood Rev, 20:71-82.
44. Mayo MW, Baldwin AS. 2000. The transcription factor NF-kappaB: control of oncogenesis and cancer therapy resistance. Biochim Biophys Acta, 1470:M55-62.
45. Meyer K, Ueberham E, Gebhardt R. 2004. Influence of organosulphur compounds from garlic on the secretion of matrix metalloproteinases and their inhibitor TIMP-1 by cultured HUVEC cells. Cell Biol Toxicol, 20:253-60.
46. Milella M, Kornblau SM, Estrov Z, et al. 2001. Therapeutic targeting of the MEK/MAPK signal transduction module in acute myeloid leukemia. J Clin Invest, 108:851-9.
47. Milner JA. 2006. Preclinical perspectives on garlic and cancer. J Nutr, 136:827S-31S.
48. Opdenakker G, Nelissen I, Van Damme J. 2003. Functional roles and therapeutic targeting of gelatinase B and chemokines in multiple sclerosis. Lancet Neurol, 2:747-56.
49. Parks WC, Wilson CL, Lopez-Boado YS. 2004. Matrix metalloproteinases as modulators of inflammation and innate immunity. Nat Rev Immunol, 4:617-29.
50. Pinto JT, Rivlin RS. 2001. Antiproliferative effects of allium derivatives from garlic. J Nutr, 131:1058S-60S.
51. Platanias LC. 2003. Map kinase signaling pathways and hematologic malignancies. Blood, 101:4667-79.
52. Plesa C, Chelghoum Y, Plesa A, et al. 2008. Prognostic value of immunophenotyping in elderly patients with acute myeloid leukemia: a singleinstitution experience. Cancer, 112:572-80.
53. Qi R, Liao F, Inoue K, et al. 2000. Inhibition by diallyl trisulfide, a garlic component, of intracellular Ca(2c) mobilization without affecting inositol-1,4, 5-trisphosphate (IP(3) formation in activated platelets. Biochem Pharmacol, 60:1475-83.
54. Rajkumar SV, Mesa RA, Tefferi A. 2002. A review of angiogenesis and anti-angiogenic therapy in hematologic malignancies. J Hematother Stem Cell Res, 11:33-47.
55. Rendu F, Brohard-Bohn B, Pain S, et al. 2001. Thiosulfinates inhibit platelet aggregation and microparticle shedding at a calpain-dependent step. Thromb Haemost, 86:1284-91.
56. Ribatti D, Scavelli C, Roccaro AM, et al. 2004. Hematopoietic cancer and angiogenesis. Stem Cells Dev, 13:484-95.
57. Sawka-Verhelle D, Escoubet-Lozach L, Fong AL, et al. 2004. PE-1/METS, an antiproliferative Ets repressor factor, is induced by CREB-1/CREM-1 during macrophage differentiation. J Biol Chem, 279:17772-84.
58. Stordeur P, Poulin LF, Craciun L, et al. 2002. Cytokine mRNA quantification by real-time PCR. J Immunol Methods, 259:55-64.
59. Sundaram SG, Milner JA. 1996a. Diallyl disulfide induces apoptosis of human colon tumor cells. Carcinogenesis, 17:669-73.
60. Sundaram SG, Milner JA. 1996b. Diallyl disulfide inhibits the proliferation of human tumor cells in culture. Biochim Biophys Acta, 1315:15-20.
61. Thomas DA, Giles FJ, Cortes J, et al. 2001. Antiangiogenic therapy in leukemia. Acta Haematol, 106:190-207.
62. Thomas X, Elhamri M. 2007. Tipifarnib in the treatment of acute myeloid leukemia. Biologics: Targets and Therapy, 1:415-24.
63. Trayner ID, Bustorff T, Etches AE, et al. 1998. Changes in antigen expression on differentiating HL60 cells treated with dimethylsulphoxide, all-trans retinoic acid, alpha1, 25-dihydroxyvitamin D3 or 12-O-tetradecanoyl phorbol-13-acetate. Leuk Res, 22:537-47.
64. Watanabe H, Nakanishi I, Yamashita K, et al. 1993. Matrix metalloproteinase-9 (92 kDa gelatinase/type IV collagenase) from U937 monoblastoid cells: correlation with cellular invasion. J Cell Sci, 104(Pt 4):991-9.
65. Westphal JR, Van't Hullenaar R, Peek R, et al. 2000. Angiogenic balance in human melanoma: expression of VEGF, bFGF, IL-8, PDGF and angiostatin in relation to vascular density of xenografts in vivo. Int J Cancer, 86:768-76.
66. Xiao D, Pinto JT, Gundersen GG, et al. 2005. Effects of a series of organosulfur compounds on mitotic arrest and induction of apoptosis in colon cancer cells. Mol Cancer Ther, 4:1388-98.
67. Xiao D, Pinto JT, Soh JW, et al. 2003. Induction of apoptosis by the garlic-derived compound S-allylmercaptocysteine (SAMC) is associated with microtubule depolymerization and c-Jun NH(2)-terminal kinase 1 activation. Cancer Res, 63:6825-37.
68. Xiao D, Singh SV. 2006. Diallyl trisulfide, a constituent of processed garlic, inactivates Akt to trigger mitochondrial translocation of BAD and caspase-mediated apoptosis in human prostate cancer cells. Carcinogenesis, 27:533-40.
69. Zheng S, Yang H, Zhang S, et al. 1997. Initial study on naturally occurring products from traditional Chinese herbs and vegetables for chemoprevention. J Cell Biochem Suppl, 27:106-12.